Drug Delivery News
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Ricoh Company, Ltd. have announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics. Read more
13 Mar 2024
Pfizer Oncology Hosts Innovation Day
Pfizer Inc. has outlined its strategic priorities for the newly formed Oncology organisation — and how its pipeline, Oncology expertise, and anticipated near- and mid-term catalysts are expected to position the company to grow strongly. Read more
1 Mar 2024
NorthSea Therapeutics Initiates Phase 2A Trial of Orziloben
NorthSea Therapeutics B.V. have announced the dosing of the first patient in its Phase 2a clinical trial of Orziloben (NST-6179) in intestinal failure-associated liver disease. Read more
21 Feb 2024
Hovione Expands Nasal Drug Delivery in Collaboration with IDC
Hovione has announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC. Read more
30 Nov 2023
NeuroOne Picks Up Patent for Drug Delivery Device
NeuroOne Medical Technologies Corporation have announced that the United States Patent and Trademark Office issued a Notice of Allowance for U.S. Patent Application 16/812,702. Read more
21 Nov 2023
First Treatment for Rare Heart Condition Accepted for Use by Scottish Medicines Consortium
Pfizer Ltd have announced that Vyndaqel (tafamidis) is accepted for use within NHS Scotland for the treatment of wild-type and hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM). Read more
13 Nov 2023
Pharmaceutical Drugs Innovations: Revolutionising Biological Drug Delivery
Professor Afzal R Mohammed, Professor of Pharmaceutics at Aston University and advisor to Max Bio+, explores two promising advancements being explored that could revolutionise biological drug delivery: liquid-based delivery and inhalation. Read more
13 Dec 2023
Innovation in Inhalation: The Future of Drug Delivery
Broughton's new inhalation testing service propels inhaled drug delivery into an innovative future. Read more
19 Jun 2023
Broughton speaks to EPM on the latest in inhaled medicines testing
EPM speaks to Chris Allen, CEO of scientific consultancy and Contract Research Organisation (CRO) Broughton, which has just launched a new inhalation testing service. Read more
8 Jun 2023
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
European Commission Approves Pfizer’s PREVENAR 20
Pfizer Inc have announced that the European Commission (EC) has granted marketing authorisation for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
ReciBioPharm and GeneVentiv Therapeutics to Partner
ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics to advance development of an Adeno-Associated Virus (AAV)-based universal gene therapy for haemophilia. Read more
18 Mar 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Tubulis Closes €128 Million Series B
Tubulis have announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
CryoLogyx Completes £500k Seed Funding Round
CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, have announced the close of its oversubscribed seed funding round. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
FDA Approves Bristol Myers Squibb’s Breyanzi
Bristol Myers Squibb have announced the U.S FDA has granted accelerated approval of Breyanzi (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25